sellWeak cluster of 310b5-1 plan
Tia L Bush sold $840k of CNTA
Chief Technology & Quality Ofc at Centessa Pharmaceuticals plc. 35,000 shares at an average of $24.00, traded Sep 24, 2025, filed Sep 24, 2025.
Warning score
23Value
$840k
35,000 shares
Holdings after
121,503
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +23Trade size$840k at market
- +5Share of holdings soldSold 22% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001470831-25-000225, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2025 | MOption exercise Ordinary Shares10b5-1 | +35,000 | $9.42 | $330k | 156,503 | Sep 24, 2025 |
| Sep 24, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -35,000 | $24.00 | $840k | 121,503 | Sep 24, 2025 |
| Sep 24, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -35,000 | $0.00 | $0 | 440,338 | Sep 24, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $1.2M 41,076 shares | -40% | |
| 25Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $2.1M 74,811 shares | -59% | |
| 25Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $3.2M 120,029 shares | -66% | |
| 14Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $288k 10,000 shares | -5% | |
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $300k 10,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.1M 40,000 shares | -25% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $166k 6,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.0M 40,000 shares | -25% | |
| 5Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $200k 8,000 shares | -4% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $134k 6,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.